tetano
Editor, Senior Moderator
PLoS One
. 2023 Sep 8;18(9):e0291212.
doi: 10.1371/journal.pone.0291212. eCollection 2023. Daily disease severity in patients with COVID-19 admitted to the hospital: The SCODA (severity of coronavirus disease assessment) score
Simone A Joosten[SUP] 1 [/SUP], Mark J R Smeets[SUP] 2 [/SUP], M Sesmu Arbous[SUP] 3 [/SUP], Judith Manniën[SUP] 4 [/SUP], Sander Laverman[SUP] 4 [/SUP], Merijn M G Driessen[SUP] 4 [/SUP], Suzanne C Cannegieter[SUP] 2 5 [/SUP], Anna H E Roukens[SUP] 1 [/SUP]; Leiden University Medical Center BEAT-COVID group
Affiliations
Background: A multitude of diagnostic and predictive algorithms have been designed for COVID-19. However, currently no score can accurately quantify and track day-to-day disease severity in hospitalised patients with COVID-19. We aimed to design such a score to improve pathophysiological insight in COVID-19.
Methods: Development of the Severity of COronavirus Disease Assessment (SCODA) score was based on the 4C Mortality score but patient demographic variables that remain constant during admission were excluded. Instead, parameters associated with breathing and oxygenation were added to reflect the daily condition. The SCODA score was subsequently applied to the BEAT-COVID cohort to describe COVID-19 severity over time and to determine the timing of clinical recovery for each patient, an important marker in pathophysiological studies. The BEAT-COVID study included patients with PCR confirmed COVID-19 who were hospitalized between April 2020 and March 2021 in the Leiden University Medical Center, The Netherlands.
Results: The SCODA score consists of 6 clinical and 2 routine lab parameters. 191 patients participated in the BEAT-COVID study. Median age was 66, and 74.4% was male. The modal timepoint at which recovery was clinically initiated occurred on days 8 and 24 since symptom onset for non-ICU and ICU-patients, respectively.
Conclusions: We developed a daily score which can be used to track disease severity of patients admitted due to COVID-19. This score is useful for improving insight in COVID-19 pathophysiology, its clinical course and to evaluate interventions. In a future stage this score can also be used in other (emerging) infectious respiratory diseases.
. 2023 Sep 8;18(9):e0291212.
doi: 10.1371/journal.pone.0291212. eCollection 2023. Daily disease severity in patients with COVID-19 admitted to the hospital: The SCODA (severity of coronavirus disease assessment) score
Simone A Joosten[SUP] 1 [/SUP], Mark J R Smeets[SUP] 2 [/SUP], M Sesmu Arbous[SUP] 3 [/SUP], Judith Manniën[SUP] 4 [/SUP], Sander Laverman[SUP] 4 [/SUP], Merijn M G Driessen[SUP] 4 [/SUP], Suzanne C Cannegieter[SUP] 2 5 [/SUP], Anna H E Roukens[SUP] 1 [/SUP]; Leiden University Medical Center BEAT-COVID group
Affiliations
- PMID: 37683031
- PMCID: PMC10490882
- DOI: 10.1371/journal.pone.0291212
Background: A multitude of diagnostic and predictive algorithms have been designed for COVID-19. However, currently no score can accurately quantify and track day-to-day disease severity in hospitalised patients with COVID-19. We aimed to design such a score to improve pathophysiological insight in COVID-19.
Methods: Development of the Severity of COronavirus Disease Assessment (SCODA) score was based on the 4C Mortality score but patient demographic variables that remain constant during admission were excluded. Instead, parameters associated with breathing and oxygenation were added to reflect the daily condition. The SCODA score was subsequently applied to the BEAT-COVID cohort to describe COVID-19 severity over time and to determine the timing of clinical recovery for each patient, an important marker in pathophysiological studies. The BEAT-COVID study included patients with PCR confirmed COVID-19 who were hospitalized between April 2020 and March 2021 in the Leiden University Medical Center, The Netherlands.
Results: The SCODA score consists of 6 clinical and 2 routine lab parameters. 191 patients participated in the BEAT-COVID study. Median age was 66, and 74.4% was male. The modal timepoint at which recovery was clinically initiated occurred on days 8 and 24 since symptom onset for non-ICU and ICU-patients, respectively.
Conclusions: We developed a daily score which can be used to track disease severity of patients admitted due to COVID-19. This score is useful for improving insight in COVID-19 pathophysiology, its clinical course and to evaluate interventions. In a future stage this score can also be used in other (emerging) infectious respiratory diseases.